Home / Expertise / Private Equity & Venture Capital
private equity golden path

Private Equity & Venture Capital


What others say about us

  • "A leading firm for private equity and venture capital, with one of the broadest practices in the market."(JUVE)
  • "The PE practice is one of the market leaders and boasts exceptional strength in breadth."(JUVE)
  • "The firm attracted a lot of interest when it was chosen to advise on the first German SPAC."(JUVE)
  • "An impressive year for a firm that has been raising its standards on all counts. Not only has the corporate practice, one of the largest in Germany, maintained its performance with another very good year, but there were some surprising developments that showed a firm in full flight and going places."(The Lawyer Awards )
  • "CMS Hasche Sigle is the leading law firm in Germany for mid-cap acquisitions."(Financial Times Deutschland)
Private Equity Expertise


Providing comprehensive advice on private equity transactions is one of our core strengths. The prestigious JUVE Handbook has long ranked our 70-headed team among Germany’s top five private equity practices. We advise our clients throughout the acquisition and ownership phases. Our successful track record of advising on large buy-out transactions is complemented by a long-established focus on the mid-cap segment.

Pioneering role

Our private equity team has carved out a pioneering role for itself in the market by developing new and innovative solutions.

Awareness of the wider context

Rather than being a private equity boutique focused purely on transactions, we have in-depth expertise in all legal areas relevant to private equity.

Market and industry expertise

The special strengths of our practice include detailed expertise across all sectors and markets.

Regional coverage

The full breadth and depth of this expertise is immediately available at all our German locations.

At home in Europe

As an integral part of CMS, the leading organisation of international law and tax firms, we offer direct access to offices in 59 locations and 33 jurisdictions. Strong partner involvement

Strong partner involvement

guarantees outstanding expertise, continuity, reliability and efficiency, plus smooth workflows throughout the CMS organisation.

Optimised advice

We are committed to tailor-made, pragmatic solutions as well as effective – and costeffective – advice.

Read more Read less

Choose area

    Venture Capital

    Our clients (investors and technology-oriented start-ups) benefit from our expertise in dynamic sectors such as biotech, cleantech, IT, medtech, pharmaceuticals, telecommunications, software and e-Commerce.

    Read more


    Show only
    CMS ad­vises In­farm on USD 170 mil­lion series C fund­ing round
    In­farm GmbH has an­ncouned a USD 170 mil­lion in­vest­ment in a series C fund­ing round. A CMS team headed by lead part­ner Dr Jörg Zätz­sch ad­vised the founders...
    22 January 2018
    In­nov­ate or your deal could die
    Any com­pany or law­yer that has ever been in­volved in any kind of mer­ger or ac­quis­i­tion trans­ac­tion will know one thing for sure – a deal typ­ic­ally in­volve hours of leg­al work, in­clud­ing of­ten mundane,...
    CMS ad­vises founders of AI start-up Semalytix on Series A fin­an­cing round
    A CMS team headed by lead part­ner Dr Jörg Zätz­sch ad­vised the founders of Semalytix on all leg­al as­pects of the fin­an­cing and as­so­ci­ated doc­u­ment­a­tion...
    One of the largest bi­otech fin­an­cing rounds in Ger­many in re­cent years:...
    A CMS team headed by lead part­ner Stefan-Ul­rich Müller ad­vised T-knife on all leg­al as­pects of the Series A fin­an­cing. CMS’s Mu­nich-based ven­ture cap­it­al and life sci­ences team has been ad­vising the bi­otech start-up on all leg­al mat­ters since its seed fin
    Private equity pan­el 2020/I sur­vey by CMS and Fin­ance: Coronavir­us causes...
    The eco­nomy is firmly in the grip of the coronavir­us crisis and the Ger­man private equity mar­ket is now also be­ing massively im­pacted. Al­most 86% of re­spond­ents in this year’s first private equity pan­el sur­vey con­duc­ted by CMS and Fin­ance magazine re­porte
    CMS ad­vises private equity firm Seafort Ad­visors on ma­jor­ity stake in soft­ware...
    Ham­burg-based private equity firm Seafort Ad­visors has ac­quired a ma­jor­ity stake in Leipzig soft­ware com­pany Desk­cen­ter AG to provide growth fin­ance, adding to its ex­ist­ing hold­ing. The fin­an­cial de­tails of the trans­ac­tion were not dis­closed. A CMS team h
    CMS ad­vises LEA Part­ners on seed fin­an­cing round for em­ploy­ee app Flip
    A CMS team headed by lead part­ner Stefan-Ul­rich Müller ad­vised LEA Part­ners on all leg­al as­pects of the fin­an­cing. LEA Part­ners is a long­stand­ing cli­ent and reg­u­larly re­lies on the ex­pert­ise of the Mu­nich-based CMS team in ven­ture cap­it­al trans­ac­tions and
    CMS ad­vises GPE and capiton on ac­quis­i­tion of NIC­OLAY Group
    A CMS team headed by lead part­ner Dr To­bi­as Schneider ad­vised GPE and capiton on all leg­al as­pects of the deal. capiton is a long­stand­ing cli­ent of CMS Ger­many. The same CMS team that has now ad­vised on the ac­quis­i­tion of the NIC­OLAY Group also ad­vised ca
    Private equity pan­el 2019/II sur­vey by CMS and Fin­ance: Loom­ing re­ces­sion...
    In fact, pur­chase prices are rated as be­ing more at­tract­ive than at any time in the last five and a half years. That is one of the key find­ings of the latest private equity pan­el sur­vey, which is con­duc­ted twice a year by CMS Ger­many and FIN­ANCE magazine.
    Private Health In­sur­ance As­so­ci­ation ad­vised by CMS on es­tab­lish­ing ven­ture...
    Frank­furt/Main – Ger­many’s Private Health In­sur­ance As­so­ci­ation (PKV) has launched the “heal cap­it­al” ven­ture cap­it­al fund to­geth­er with Ber­lin-based di­git­al health in­vestors Heart­beat Labs and Fly­ing Health...
    June 2019
    CMS Private Equity Glob­al Bro­chure
    CMS ad­vises on spin-off and fin­an­cing of Break­point Thera­peut­ics GmbH
    A CMS team headed by lead part­ner Stefan-Ul­rich Müller again ad­vised Evotec on all leg­al as­pects of the spin-off and ven­ture cap­it­al fin­an­cing...